FMP
Unity Biotechnology, Inc.
UBX
NASDAQ
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
1.5 USD
0.02 (1.33%)
About
ceo
Dr. Anirvan Ghosh Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://unitybiotechnology.com
exchange
NASDAQ
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed ...
CIK
0001463361
ISIN
US91381U2006
CUSIP
91381U101
Address
285 East Grand Avenue
Phone
650 416 1192
Country
US
Employee
19
IPO Date
May 3, 2018
Summary
CIK
0001463361
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
91381U101
ISIN
US91381U2006
Country
US
Price
1.5
Beta
0.87
Volume Avg.
90.51k
Market Cap
25.18M
Shares
-
52-Week
1.46-3.82
DCF
-0.49
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.56
P/B
-
Website
https://unitybiotechnology.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest UBX News
It looks like there's no news available.
